7,650.00

-30.50

-0.40%

52,488.00

-344.00

-0.65%

29,391.25

-147.50

-0.50%

Russell 2000 Futures

2,944.90

-18.70

-0.63%

16.50

+0.78

+4.96%

4,443.20

+4.20

+0.09%

78,833.98

+432.09

+0.55%

Crude Oil Oct 26

94.92

+1.89

+2.03%

ASX - Delayed Quote AUD

CSL Limited (CSL.AX)

Get top stock picks

171.21 -3.59 (-2.05%)

At close: 4:10:10 PM GMT+10

Get top stock picks

Loading Chart for CSL.AX

Chart Range Bar

Interval:

In partnership with ChartIQ

Should Value Investors Buy CSL Limited (CSLLY) Stock?

Should Value Investors Buy CSL Limited (CSLLY) Stock?

CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)

CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

CSLLY vs. ACAD: Which Stock Should Value Investors Buy Now?

Imugene strengthens board with biotech and pharma appointments

Imugene strengthens board with biotech and pharma appointments

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

CSLLY vs. ACAD: Which Stock Is the Better Value Option?

CSLLY vs. ACAD: Which Stock Is the Better Value Option?

Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms

Trump Strikes Medicaid Drug Price Deals With Nine Pharma Firms

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union

CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada

CSL Canada Announces First Canadian Patient Receives HEMGENIX® (etranacogene dezaparvovec) Hemophilia B Gene Therapy in Ontario, Canada

CSL Plunges 22% After Cutting Outlook And Flagging $5 Billion Impairments

CSL Plunges 22% After Cutting Outlook And Flagging $5 Billion Impairments

CSL Restructure And Seqirus Split Reset Expectations After Share Price Slide

CSL Restructure And Seqirus Split Reset Expectations After Share Price Slide

TLX.AX

NEU.AX

MSB.AX

CUV.AX

TLX

IMM.AX

CU6.AX

RAC.AX

OCC.AX

BOT.AX

Mobilize your Website

View Site in Mobile | Classic

Share by: